Quoin Pharmaceuticals, Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.63 | -$0.63 | -$0.63 |
| Q2 2024 | 2 | -$0.53 | -$0.53 | -$0.53 |
| Q3 2024 | 0 | -$0.54 | -$0.54 | -$0.54 |
| Q1 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2025 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2025 | 1 | -$0.47 | -$0.47 | -$0.47 |
Quoin Pharmaceuticals, Ltd. Earnings Date And Information
Quoin Pharmaceuticals, Ltd. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.39 earnings per share for the quarter, topping analysts' consensus estimates of $-0.75 by $0.36. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Quoin Pharmaceuticals, Ltd. has generated $-10 earnings per share over the last year ($-9.62 diluted earnings per share) and currently has a price-to-earnings ratio of -0.37. Quoin Pharmaceuticals, Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Quoin Pharmaceuticals, Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$0.75 | -$0.39 | 0.36 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.76 | -$1.12 | -0.36 | $0 | |
| 03/14/2024 | Q4 2023 | -$2.10 | $154,774 | |||
| 11/09/2023 | Q3 2023 | -$1.95 | $0 | |||
| 08/03/2023 | Q2 2023 | -$2.13 | $0 | |||
| 05/09/2023 | Q1 2023 | -$2.42 | $0 | |||
| 03/15/2023 | Q4 2022 | -$4.89 | $0 | |||
| 11/10/2022 | Q3 2022 | -$34.81 | -$13.64 | 21.17 | $0 | |
| 05/23/2022 | Q2 2022 | -$3.31 | -$9.72 | -6.41 | $0 | |
| 05/23/2022 | Q1 2022 | -$3.31 | -$21.28 | -17.97 | $0 | |
| 04/13/2022 | Q4 2021 | -$476,811.52 | $0 | |||
| 09/29/2021 | Q3 2021 | -$70.21 | $0 | |||
| 06/29/2021 | Q2 2021 | -$216.88 | $0 | |||
| 03/31/2021 | Q1 2021 | -$195.19 | $0 | |||
| 03/29/2021 | Q4 2020 | -$12.73 | $0 | |||
| 09/29/2020 | Q3 2020 | -$16.41 | $0 | |||
| 02/11/2021 | Q2 2020 | -$17.51 | $0 | |||
| 02/11/2021 | Q1 2020 | -$33.87 | $0 |
Quoin Pharmaceuticals, Ltd. Earnings: Frequently Asked Questions
-
When is Quoin Pharmaceuticals, Ltd.'s earnings date?
Quoin Pharmaceuticals, Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did Quoin Pharmaceuticals, Ltd. beat their earnings estimates last quarter?
In the previous quarter, Quoin Pharmaceuticals, Ltd. (:QNRX) reported $-0.39 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.75 by $0.36.
-
How can I listen to Quoin Pharmaceuticals, Ltd.'s earnings conference call?
The conference call for Quoin Pharmaceuticals, Ltd.'s latest earnings report can be listened to online.
-
How can I read Quoin Pharmaceuticals, Ltd.'s conference call transcript?
The conference call transcript for Quoin Pharmaceuticals, Ltd.'s latest earnings report can be read online.
-
How much profit does Quoin Pharmaceuticals, Ltd. generate each year?
Quoin Pharmaceuticals, Ltd. (:QNRX) has a recorded net income of $0. Quoin Pharmaceuticals, Ltd. has generated $-9.62 earnings per share over the last four quarters.
-
What is Quoin Pharmaceuticals, Ltd.'s price-to-earnings ratio?
Quoin Pharmaceuticals, Ltd. (:QNRX) has a price-to-earnings ratio of -0.37 and price/earnings-to-growth ratio is -0.01.
